CIK 0001509261 · Non-accelerated filer<br>Smaller reporting company
Rezolute, Inc.
Sign in to watch- Ticker
- RZLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 273440894
- Phone
- 650-206-4507
- Business address
- 275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY, CA, 94065
- Former names
- AntriaBio, Inc., FITS MY STYLE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-14 | Elam Nevan C Chief Executive Officer | Returned to the company · Stock Option (right to buy) | −34,800 | 0 | ||
| 2021-06-14 | Elam Nevan C Chief Executive Officer | Returned to the company · Stock Option (right to buy) | −70,000 | 0 | ||
| 2021-06-14 | Elam Nevan C Chief Executive Officer | Grant or award · Stock Option (right to buy) | +375,000 | 675,000 | ||
| 2021-06-14 | Elam Nevan C Chief Executive Officer | Returned to the company · Stock Option (right to buy) | −100,000 | 575,000 | ||
| 2021-06-14 | Hogenhuis Wladimir Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2021-06-14 | FAUCHET PHILIPPE Director | Grant or award · Stock Option (right to buy) | +2,000 | 2,000 | ||
| 2021-06-14 | KREHER NERISSA Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2021-06-14 | Labrucherie Gil M Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2021-06-14 | ROBERTS BRIAN KENNETH Sr VP, Clinic Development | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2021-06-14 | ROBERTS BRIAN KENNETH Sr VP, Clinic Development | Returned to the company · Stock Option (right to buy) | −9,000 | 0 | ||
| 2021-06-14 | ROBERTS BRIAN KENNETH Sr VP, Clinic Development | Returned to the company · Stock Option (right to buy) | −20,000 | 0 | ||
| 2021-06-14 | Elam Nevan C Chief Executive Officer | Returned to the company · Stock Option (right to buy) | −34,800 | 0 | ||
| 2021-06-14 | Elam Nevan C Chief Executive Officer | Returned to the company · Stock Option (right to buy) | −70,000 | 0 | ||
| 2021-06-14 | Elam Nevan C Chief Executive Officer | Grant or award · Stock Option (right to buy) | +375,000 | 675,000 | ||
| 2021-06-14 | Elam Nevan C Chief Executive Officer | Returned to the company · Stock Option (right to buy) | −100,000 | 575,000 | ||
| 2020-10-13 | HANDOK, INC. 10% owner | Purchase | +2,500 | $23.35 | $58K | 2,015,491 |
| 2020-10-12 | HANDOK, INC. 10% owner | Purchase | +125,000 | $0.46 | $58K | 100,649,528 |
| 2020-10-07 | HANDOK, INC. 10% owner | Purchase | +125,000 | $0.41 | $51K | 100,524,528 |
| 2020-10-06 | HANDOK, INC. 10% owner | Purchase | +125,000 | $0.42 | $53K | 100,399,528 |
| 2020-10-05 | HANDOK, INC. 10% owner | Purchase | +125,000 | $0.46 | $57K | 100,274,528 |
Page 8 of 14 · 279 trades